Genetic alterations in colorectal cancers with demethylation of insulin-like growth factor II

Human Pathology

Volumn 39, Issue 9, 2008, Pages 1301-1308

  Ohta, Miki ^a,b   Sugimoto, Takafumi ^a   Seto, Motoko ^a   Mohri, Dai ^a   Asaoka, Yoshinari ^a   Tada, Motohisa ^a,c   Tanaka, Yasuo ^a   Yamaji, Yutaka ^a   Kanai, Fumihiko ^a   Kawabe, Takao ^a,b   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Colorectal neoplasms; Insulin like growth factor II; Loss of genomic imprinting

Indexed keywords

B RAF KINASE; BISULFITE; CTNNB1 PROTEIN; GENOMIC DNA; K RAS PROTEIN; PIK3CA PROTEIN; PROTEIN; PROTEIN P53; SOMATOMEDIN B;

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER TISSUE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DESCENDING COLON; DNA DETERMINATION; DNA METHYLATION; FEMALE; GENE MUTATION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PATHOLOGY; SEQUENCE ANALYSIS; STATISTICAL SIGNIFICANCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; BETA CATENIN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 48949097375     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.02.005     Document Type: Article

References (55)

1. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4 (2004) 505-518
2. Lahm H., Suardet L., Laurent P.L., et al. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer 65 (1992) 341-346
3. Gelato M.C., and Vassalotti J. Insulin-like growth factor-II: possible local growth factor in pheochromocytoma. J Clin Endocrinol Metab 71 (1990) 1168-1174
4. El-Badry O.M., Helman L.J., Chatten J., et al. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87 (1991) 648-657
5. Yee D., Cullen K.J., Paik S., et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48 (1988) 6691-6696
6. Lamonerie T., Lavialle C., Haddada H., et al. IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. Int J Cancer 61 (1995) 587-592
7. Pommier G.J., Garrouste F.L., el Atiq F., et al. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line. Cancer Res 52 (1992) 3182-3188
8. Freier S., Weiss O., Eran M., et al. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 44 (1999) 704-708
9. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat Rev Cancer 4 (2004) 143-153
10. Kaneda A., and Feinberg A.P. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res 65 (2005) 11236-11240
11. DeChiara T.M., Robertson E.J., and Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64 (1991) 849-859
12. Ogawa O., Eccles M.R., Szeto J., et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362 (1993) 749-751
13. Rainier S., Johnson L.A., Dobry C.J., et al. Relaxation of imprinted genes in human cancer. Nature 362 (1993) 747-749
14. Yun K., Fukumoto M., and Jinno Y. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer. Am J Pathol 148 (1996) 1081-1087
15. Cui H., Horon I.L., Ohlsson R., et al. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4 (1998) 1276-1280
16. Kondo M., Suzuki H., Ueda R., et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10 (1995) 1193-1198
17. Cui H., Cruz-Correa M., Giardiello F.M., et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299 (2003) 1753-1755
18. Woodson K., Flood A., Green L., et al. Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J Natl Cancer Inst 96 (2004) 407-410
19. Kinouchi Y., Hiwatashi N., Higashioka S., et al. Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer. Cancer Lett 107 (1996) 105-108
20. Tanaka K., Shiota G., Meguro M., et al. Loss of imprinting of long QT intronic transcript 1 in colorectal cancer. Oncology 60 (2001) 268-273
21. Sasaki J., Konishi F., Kawamura Y.J., et al. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2. Int J Cancer 119 (2006) 80-83
22. Cruz-Correa M., Cui H., Giardiello F.M., et al. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 126 (2004) 964-970
23. Sakatani T., Kaneda A., Iacobuzio-Donahue C.A., et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307 (2005) 1976-1978
24. Miyaki M., Seki M., Okamoto M., et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 50 (1990) 7166-7173
25. Capon D.J., Seeburg P.H., McGrath J.P., et al. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304 (1983) 507-513
26. Davies H., Bignell G.R., Cox C., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
27. Samuels Y., Wang Z., Bardelli A., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
28. Young J., Leggett B., Gustafson C., et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum mutat 2 (1993) 351-354
29. Makos M., Nelkin B.D., Lerman M.I., et al. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci U S A 89 (1992) 1929-1933
30. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
31. Tateishi K., Ohta M., Kanai F., et al. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 12 (2006) 6960-6966
32. Shao R.X., Kato N., Lin L.J., et al. Absence of tyrosine kinase mutations in Japanese colorectal cancer patients. Oncogene 26 (2007) 2133-2135
33. Tanaka Y., Kanai F., Tada M., et al. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients. Oncogene 25 (2006) 2950-2952
34. Suraweera N., Duval A., Reperant M., et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123 (2002) 1804-1811
35. Buhard O., Suraweera N., Lectard A., et al. Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis Markers 20 (2004) 251-257
36. Barnetson R.A., Tenesa A., Farrington S.M., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751-2763
37. Ohta M., Tateishi K., Kanai F., et al. p53-Independent negative regulation of p21/cyclin-dependent kinase-interacting protein 1 by the sonic hedgehog-glioma-associated oncogene 1 pathway in gastric carcinoma cells. Cancer Res 65 (2005) 10822-10829
38. Rodrigues N.R., Rowan A., Smith M.E., et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 87 (1990) 7555-7559
39. Davidoff A.M., Humphrey P.A., Iglehart J.D., et al. Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci U S A 88 (1991) 5006-5010
40. Fransen K., Klintenas M., Osterstrom A., et al. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25 (2004) 527-533
41. Lee E.J., Choi C., Park C.K., et al. Tracing origin of serrated adenomas with BRAF and KRAS mutations. Virchows Arch 447 (2005) 597-602
42. Samowitz W.S., Albertsen H., Herrick J., et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129 (2005) 837-845
43. Thibodeau S.N., French A.J., Cunningham J.M., et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58 (1998) 1713-1718
44. Takano Y., Shiota G., and Kawasaki H. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 59 (2000) 210-216
45. Nishihara S., Hayashida T., Mitsuya K., et al. Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. Int J Oncol 17 (2000) 317-322
46. Nakagawa H., Chadwick R.B., Peltomaki P., et al. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A 98 (2001) 591-596
47. Maenaka S., Hikichi T., Imai M.A., et al. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection. Oncol Rep 15 (2006) 791-795
48. Okamoto M., Shiratori Y., Yamaji Y., et al. Relationship between age and site of colorectal cancer based on colonoscopy findings. Gastrointest Endosc 55 (2002) 548-551
49. Yamaji Y., Mitsushima T., Ikuma H., et al. Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese. Gut 53 (2004) 568-572
50. Yamaji Y., Mitsushima T., Ikuma H., et al. Right-side shift of colorectal adenomas with aging. Gastrointest Endosc 63 (2006) 453-458 quiz 464
51. Togo G., Toda N., Kanai F., et al. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. Cancer Res 56 (1996) 5620-5623
52. van Rijnsoever M., Grieu F., Elsaleh H., et al. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51 (2002) 797-802
53. Pretlow T.P., and Pretlow T.G. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer?. Biochim Biophys Acta 1756 (2005) 83-96
54. van Wyk R., Slezak P., Hayes V.M., et al. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas. Genes Chromosomes Cancer 27 (2000) 202-208
55. Yuen S.T., Davies H., Chan T.L., et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62 (2002) 6451-6455